Sempermed Launches New and Improved SemperShield Extended Cuff Nitrile Examination Glove
Sempermed USA announces the reintroduction of the SemperShield® Extended Cuff Nitrile Examination glove. The new and improved gloves are available for those in need of a 12-inch, powder-free, latex-free, exam glove. The new manufacturing process produces a glove that is incredibly comfortable, elastic, and durable. The textured fingertips provide a grip that allows for complete control in both wet and dry environments, and the extended cuff provides extra protection to the wrist and lower forearm. Additionally, SemperShield® Extended Cuff Nitrile Exam gloves have been tested for use with chemotherapy drugs, which makes these gloves the ideal choice when handling caustic and hazardous chemicals.
The superior SemperShield® Extended Cuff Nitrile Exam gloves are available in sizes Small through XX-Large and are packed with 50 gloves per dispenser box, 10 dispenser boxes per case. The product reorder numbers are SSNF102 (size small), SSNF103 (size medium), SSNF104 (size large), SSNF105 (size x-large) and size SSNF106 (size xx-large).
Source: Sempermed USA
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
